168 related articles for article (PubMed ID: 24496339)
1. Role of D-dimer in predicting mortality in patients with community-acquired pneumonia.
Nastasijević Borovac D; Radjenović Petković T; Pejčić T; Stanković I; Janković I; Ćirić Z; Rančić M
Med Glas (Zenica); 2014 Feb; 11(1):37-43. PubMed ID: 24496339
[TBL] [Abstract][Full Text] [Related]
2. [Coagulopathy correlates with outcomes in patients with community- acquired pneumonia].
Zhuang Q; Zeng Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):406-10. PubMed ID: 25200038
[TBL] [Abstract][Full Text] [Related]
3. D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial.
Snijders D; Schoorl M; Schoorl M; Bartels PC; van der Werf TS; Boersma WG
Eur J Intern Med; 2012 Jul; 23(5):436-41. PubMed ID: 22726372
[TBL] [Abstract][Full Text] [Related]
4. The impact of coagulation parameters on the outcomes of patients with severe community-acquired pneumonia requiring intensive care unit admission.
Salluh JIF; Rabello LSCF; Rosolem MM; Soares M; Bozza FA; Verdeal JCR; Mello GW; Castro Faria Neto HC; Lapa E Silva JR; Bozza PT
J Crit Care; 2011 Oct; 26(5):496-501. PubMed ID: 21454038
[TBL] [Abstract][Full Text] [Related]
5. Plasma d-dimer levels increase with the severity of community acquired pneumonia.
Güneysel O; Pirmit S; Karakurt S
Tuberk Toraks; 2004; 52(4):341-7. PubMed ID: 15558356
[TBL] [Abstract][Full Text] [Related]
6. Elevated Plasma D-Dimer in Adult Community-Acquired Pneumonia Patients is Associated with an Increased Inflammatory Reaction and Lower Survival.
Ge YL; Liu CH; Wang N; Xu J; Zhu XY; Su CS; Li HL; Zhang HF; Li ZZ; Li HL; Zhang X; Chen H; Yu HL; Fu AS; Wang HY
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775898
[TBL] [Abstract][Full Text] [Related]
7. Admission D-dimer can identify low-risk patients with community-acquired pneumonia.
Chalmers JD; Singanayagam A; Scally C; Hill AT
Ann Emerg Med; 2009 May; 53(5):633-8. PubMed ID: 19201061
[TBL] [Abstract][Full Text] [Related]
8. Coagulation and inflammation biomarkers may help predict the severity of community-acquired pneumonia.
Agapakis DI; Tsantilas D; Psarris P; Massa EV; Kotsaftis P; Tziomalos K; Hatzitolios AI
Respirology; 2010 Jul; 15(5):796-803. PubMed ID: 20497384
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department].
Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Sicilia-Bravo I; Palomo-de Los Reyes MJ; Cabezas-Martínez A; Laín-Terés N; Estebaran-Martín J; Lozano-Ancín A; Cuena-Boy R
Enferm Infecc Microbiol Clin; 2014 Apr; 32(4):225-35. PubMed ID: 24182623
[TBL] [Abstract][Full Text] [Related]
10. D-dimer as A Biomarker of Severity and Adverse Outcomes in Patients with Community Acquired Pneumonia.
Cerda-Mancillas MC; Santiago-Germán D; Andrade-Bravo B; Pedraza-Olivares F; Valenzo-Hernández F; Leaños-Miranda A; Isordia-Salas I
Arch Med Res; 2020 Jul; 51(5):429-435. PubMed ID: 32402575
[TBL] [Abstract][Full Text] [Related]
11. Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia.
Querol-Ribelles JM; Tenias JM; Grau E; Querol-Borras JM; Climent JL; Gomez E; Martinez I
Chest; 2004 Oct; 126(4):1087-92. PubMed ID: 15486368
[TBL] [Abstract][Full Text] [Related]
12. Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia.
Christ-Crain M; Stolz D; Jutla S; Couppis O; Müller C; Bingisser R; Schuetz P; Tamm M; Edwards R; Müller B; Grossman AB
Am J Respir Crit Care Med; 2007 Nov; 176(9):913-20. PubMed ID: 17702966
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of haemostasis and endothelial dysfunction characteristics in patient with community-acquired pneumonia].
Bedilo NV; Vorob'eva NA; Ismaĭlova NV; Veshchagina NA; Nasonov IIa; Malugin IuIu
Anesteziol Reanimatol; 2014; (1):33-8. PubMed ID: 24749306
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia.
Menéndez R; Martínez R; Reyes S; Mensa J; Filella X; Marcos MA; Martínez A; Esquinas C; Ramirez P; Torres A
Thorax; 2009 Jul; 64(7):587-91. PubMed ID: 19131448
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.
Thiem U; Niklaus D; Sehlhoff B; Stückle C; Heppner HJ; Endres HG; Pientka L
Age Ageing; 2009 Nov; 38(6):693-7. PubMed ID: 19729453
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of relevant indicators of coagulation and fibrinolysis in patients with varying severity of community-acquired pneumonia].
Xu Y; Zhang Y; Jiang F; Zheng H; Zhang Y; Pang G; Yang L; Zhang Q
Zhonghua Yi Xue Za Zhi; 2015 Jun; 95(24):1925-9. PubMed ID: 26710695
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department].
Chen Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Feb; 26(2):115-9. PubMed ID: 24524403
[TBL] [Abstract][Full Text] [Related]
18. A rapid quantitative D-dimer assay at admission correlates with the severity of community acquired pneumonia.
Shilon Y; Shitrit AB; Rudensky B; Yinnon AM; Margalit M; Sulkes J; Shitrit D
Blood Coagul Fibrinolysis; 2003 Dec; 14(8):745-8. PubMed ID: 14614354
[TBL] [Abstract][Full Text] [Related]
19. Plasma d-dimer for outcome assessment in patients with CAP: not a replacement for PSI.
McIvor RA
Chest; 2004 Oct; 126(4):1015-6. PubMed ID: 15486354
[No Abstract] [Full Text] [Related]
20. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.
Lee JH; Kim J; Kim K; Jo YH; Rhee J; Kim TY; Na SH; Hwang SS
J Crit Care; 2011 Jun; 26(3):287-94. PubMed ID: 21129911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
